DR.REDDYS LABORATORIES SAS — Bevacizumab Importer Profile
Pharmaceutical Importer · #5 buyer for Bevacizumab · $987.1K import value · 21 shipments · COLOMBIA · DGFT Verified
DR.REDDYS LABORATORIES SAS is the #5 importer of Bevacizumab from India with $987.1K in import value and 21 verified shipments. DR.REDDYS LABORATORIES SAS holds a 2.2% market share in Bevacizumab imports based in COLOMBIA. The company sources from 2 verified suppliers across 15 formulations shipped to 1 country.
DR.REDDYS LABORATORIES SAS — Bevacizumab Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Bevacizumab to DR.REDDYS LABORATORIES SAS?
Verified from 21 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| DR.REDDY'S LABORATORIES LIMITED | $937.1K | 20 | 94.9% |
| DR REDDYS LABORATORIES LIMITED | $50.0K | 1 | 5.1% |
DR.REDDYS LABORATORIES SAS sources Bevacizumab from 2 verified Indian suppliers based on 21 customs records. The primary supplier is DR.REDDY'S LABORATORIES LIMITED accounting for 94.9% of imports.
How Does DR.REDDYS LABORATORIES SAS Compare to Nearest Bevacizumab Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | JSC R-PHARM | RUSSIA | $2.5M | 51 | $50.0K |
| 7 | SEAN DOMINICAN SRL | DOMINICAN REPUBLIC | $1.0M | 30 | $33.6K |
| 5 | DR.REDDYS LABORATORIES SAS ★ | COLOMBIA | $1.0M | 20 | $50.0K |
| 3 | BIOCON BIOLOGICS UK LIMITED | NETHERLANDS | $900.0K | 18 | $50.0K |
| 2 | JSC R PHARM | RUSSIA | $750.0K | 15 | $50.0K |
DR.REDDYS LABORATORIES SAS ranks #5 among 346 Bevacizumab importers from India. Average shipment value of $50.0K compared to the market average of $24.2K. The closest competitors by value are JSC R-PHARM and SEAN DOMINICAN SRL.
Where Does DR.REDDYS LABORATORIES SAS Import Bevacizumab To?
Destination countries from 21 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| COLOMBIA | $987.1K | 21 | 100.0% |
DR.REDDYS LABORATORIES SAS imports Bevacizumab to 1 country. The primary destination is COLOMBIA receiving 100.0% of shipments worth $987.1K.
What Bevacizumab Formulations Does DR.REDDYS LABORATORIES SAS Import?
| Formulation | Value | Shipments |
|---|---|---|
| PERSIVIA 100MG/4ML(BEVACIZUMAB(1S))(QTY: | $250.0K | 5 |
| PERSIVIA 100MG/4ML(BEVACIZUMAB)[1S](QTY: | $150.0K | 3 |
| PERSIVIA 100MG/4MLBEVACIZUMAB1SQTY:2807 VIALS | $50.0K | 1 |
| PERSIVIA 100 MG/4 ML(BEVACIZUMAB)(1S)(QTY:2799 VIALS) | $50.0K | 1 |
| PERSIVIA 100 MG/4 ML(BEVACIZUMAB)(1S)(QTY:1201 VIALS) | $50.0K | 1 |
| PERSIVIA 100MG/4ML (1S)(BEVACIZUMAB)(QTY:2693 VIALS) | $50.0K | 1 |
| PERSIVIA 100MG/4ML (1S)(BEVACIZUMAB)(QTY: 2692 VIALS) | $50.0K | 1 |
| PERSIVIA 100MG/4ML (1S)(BEVACIZUMAB)(QTY: 1508 VIALS) | $50.0K | 1 |
| PERSIVIA 100MG/4ML(BEVACIZUMAB)(1S)(QTY:2624 VIALS) | $50.0K | 1 |
| PERSIVIA 100MG/4ML(BEVACIZUMAB)(1S)(QTY:1862 VIALS) | $50.0K | 1 |
DR.REDDYS LABORATORIES SAS imports 15 distinct Bevacizumab formulations from India. The top formulation is PERSIVIA 100MG/4ML(BEVACIZUMAB(1S))(QTY: with 5 shipments worth $250.0K.
Who Are the Top Buyers of Bevacizumab from India and How Much Does DR.REDDYS LABORATORIES SAS Import?
India exported $8.4M worth of Bevacizumab through 1,408 shipments from 196 suppliers to 100 countries, serving 346 buyers globally. DR.REDDYS LABORATORIES SAS imports $987.1K of this total, accounting for 2.2% of India's Bevacizumab exports with 21 shipments from COLOMBIA. This is verified from 21 customs shipment records covering 15 distinct formulations.
What Is the Average Order Value for DR.REDDYS LABORATORIES SAS's Bevacizumab Imports?
DR.REDDYS LABORATORIES SAS's average Bevacizumab order value is $47.0K per consignment, based on 21 shipments totaling $987.1K. DR.REDDYS LABORATORIES SAS is based in COLOMBIA and ranks #5 among all Bevacizumab importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Bevacizumab to DR.REDDYS LABORATORIES SAS?
DR.REDDYS LABORATORIES SAS sources Bevacizumab from 2 verified Indian suppliers: DR.REDDY'S LABORATORIES LIMITED ($937.1K, 94.9%), DR REDDYS LABORATORIES LIMITED ($50.0K, 5.1%). This is based on 21 customs records.
How Does DR.REDDYS LABORATORIES SAS Compare to Other Bevacizumab Importers?
DR.REDDYS LABORATORIES SAS ranks #5 among 346 Bevacizumab importers from India with a 2.2% market share. The top 3 importers are JSC R-PHARM ($2.5M), SEAN DOMINICAN SRL ($1.0M), DR.REDDYS LABORATORIES SAS ($1.0M). DR.REDDYS LABORATORIES SAS processed 21 shipments from COLOMBIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bevacizumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bevacizumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: DR.REDDYS LABORATORIES SAS matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as DR.REDDYS LABORATORIES SAS's capped import value divided by total capped export value for Bevacizumab across all Indian exporters.
- 5.Verified Records: This page is backed by 21 individual customs records matching DR.REDDYS LABORATORIES SAS importing Bevacizumab, covering 15 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 346+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bevacizumab Import Data for DR.REDDYS LABORATORIES SAS
Access order-level details, pricing data, supplier connections, and competitive analysis for DR.REDDYS LABORATORIES SAS's Bevacizumab imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DR.REDDYS LABORATORIES SAS
Company Profile
Multiple products · $0 total trade · Multiple categories
DR.REDDYS LABORATORIES SAS × Bevacizumab
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for DR.REDDYS LABORATORIES SAS.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bevacizumab. For current order-level data, contact TransData Nexus.